| An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases |
76 |
| Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update |
52 |
| The Effects of Exercise and Physical Activity on Weight Loss and Maintenance |
36 |
| Cardiorespiratory fitness and cardiovascular disease - The past, present, and future |
34 |
| Obesity and the Obesity Paradox in Heart Failure |
34 |
| An Update on the Role of Cardiorespiratory Fitness, Structured Exercise and Lifestyle Physical Activity in Preventing Cardiovascular Disease and Health Risk |
33 |
| Obesity and Cardiac Remodeling in Adults: Mechanisms and Clinical Implications |
29 |
| Mediterranean Diet and Cardiovascular Disease Prevention: What Do We Know? |
27 |
| Global physical activity levels - Need for intervention |
26 |
| Alcohol and CV Health: Jekyll and Hyde J-Curves |
21 |
| Guidelines for the delivery and monitoring of high intensity interval training in clinical populations |
21 |
| The Association between the Change in Directly Measured Cardiorespiratory Fitness across Time and Mortality Risk |
20 |
| Portfolio Dietary Pattern and Cardiovascular Disease: A Systematic Review and Meta-analysis of Controlled Trials |
18 |
| Mechanistic insights regarding the role of SGLT2 inhibitors and GLP1 agonist drugs on cardiovascular disease in diabetes |
18 |
| Diabetic cardiomyopathy - A comprehensive updated review |
18 |
| Obesity Paradox in Aging: From Prevalence to Pathophysiology |
17 |
| Nuts and Cardiovascular Disease |
17 |
| Obesity and Kidney Disease |
16 |
| Prognostic Implications of Left Ventricular Hypertrophy |
16 |
| Vegetarian Dietary Patterns and Cardiovascular Disease |
16 |
| Diabetes, heart failure, and renal dysfunction: The vicious circles |
15 |
| Are the neuroprotective effects of exercise training systemically mediated? |
14 |
| The Contributions of 'Diet', 'Genes', and Physical Activity to the Etiology of Obesity: Contrary Evidence and Consilience |
14 |
| A role for FNDC5/Irisin in the beneficial effects of exercise on the brain and in neurodegenerative diseases |
14 |
| Role of Physical Activity and Fitness in the Characterization and Prognosis of the Metabolically Healthy Obesity Phenotype: A Systematic Review and Meta-analysis |
14 |
| Obesity, risk of diabetes and role of physical activity, exercise training and cardiorespiratory fitness |
14 |
| The Joint Association of Fitness and Fatness on Cardiovascular Disease Mortality: A Meta-Analysis |
13 |
| Evolution of Coronary Stent Technology and Implications for Duration of Dual Antiplatelet Therapy |
12 |
| Fructose-induced inflammation and increased cortisol: A new mechanism for how sugar induces visceral adiposity |
11 |
| Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health: A Comprehensive Review |
11 |
| Physical activity, exercise and cardiac troponins: Clinical implications |
10 |
| Obesity Paradox in Advanced Kidney Disease: From Bedside to the Bench |
10 |
| Weight Loss Strategies for Treatment of Obesity: Lifestyle Management and Pharmacotherapy |
10 |
| Metabolic and Bariatric Surgery: An Effective Treatment Option for Obesity and Cardiovascular Disease |
10 |
| Coffee for Cardioprotection and Longevity |
10 |
| The 2018 AHA/ACC/Multi-Society Cholesterol guidelines: Looking at past, present and future |
10 |
| Understanding why REDUCE-IT was positive - Mechanistic overview of eicosapentaenoic acid |
9 |
| Cardiovascular outcome trials of the newer anti-diabetic medications |
9 |
| Non-alcoholic fatty liver disease: Prevalence and all-cause mortality according to sedentary behaviour and cardiorespiratory fitness. The HUNT Study |
9 |
| Curing breast cancer and killing the heart: A novel model to explain elevated cardiovascular disease and mortality risk among women with early stage breast cancer |
8 |
| Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
8 |
| Sudden cardiac death in Long QT syndrome (LQTS), Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT) |
8 |
| Obesity and Ventricular Repolarization: a Comprehensive Review |
8 |
| Role of Human Brown Fat in Obesity, Metabolism and Cardiovascular Disease: Strategies to Turn Up the Heat |
8 |
| Evidence-Based Exercise Recommendations to Reduce Hepatic Fat Content in Youth- a Systematic Review and Meta-Analysis |
8 |
| Depressive and Anxiety Symptoms in Adult Congenital Heart Disease: Prevalence, Health Impact and Treatment |
8 |
| Thiamine and Cardiovascular Disease: A Literature Review |
8 |
| Impact of fitness and changes in fitness on lipids and survival |
7 |
| Precision medicine and healthy living: The importance of the built environment |
7 |
| Meta-analysis of Exercise Training on Left Ventricular Ejection Fraction in Heart Failure with Reduced Ejection Fraction: A 10-year Update |
7 |
